Polo, Nahwaf .

HRN: 22-55-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
CEFUROXIME 750MG (VIAL)
08/20/2025
08/27/2025
IV
750mg
Q8h
BA In AE; PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines